Placental infiltration of inflammatory markers in gestational diabetic women

General Physiology and Biophysics

Volumn 33, Issue 2, 2014, Pages 169-176

  Mrizak, Ines ^a,b   Grissa, Oussama ^a,b   Henault, Benoit ^a   Fekih, Mariem ^b   Bouslema, Ali ^c   Boumaiza, Imen ^c   Zaouali, Monia ^b   Tabka, Zouhair ^b   Khan, Naim A ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b FARHAT HACHED HOSPITAL   (Tunisia)

^c SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

Gestational diabetes mellitus; Inflammation; Macrosomia; Placenta

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD14 ANTIGEN; CHLORDANE; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE RECEPTOR; INSULIN; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MUCIN LIKE HORMONE RECEPTOR 1; PROTEIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URIC ACID;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; DIABETIC PATIENT; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; INSULIN BLOOD LEVEL; INSULINEMIA; MACROPHAGE; MACROSOMIA; NEWBORN; PATHOGENESIS; PLACENTA; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; REAL TIME POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES, GESTATIONAL; FEMALE; GENE EXPRESSION REGULATION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFLAMMATION; INSULIN; PLACENTA; PREGNANCY; RNA, MESSENGER; YOUNG ADULT;

EID: 84904915657     PISSN: 02315882     EISSN: 13384325     Source Type: Journal    
DOI: 10.4149/gpb_2013075     Document Type: Article

References (48)

1. Atègbo J. M., Grissa O., Yessoufou A., Hichami A., Dramane K. L., Moutairou K., Miled A., Grissa A., Jerbi M., Tabka Z., Khan N. A. (2006): Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J. Clin. Endocrinol. Metab. 91, 4137-4143 http://dx.doi.org/10.1210/jc.2006-0980
2. Bajoria R., Sooranna S. R., Ward B. S., Chatterjee R. (2002): Prospective function of placental leptin at maternal-fetal interface. Placenta 23, 103-115 http://dx.doi.org/10.1053/plac.2001.0769
3. Bastard J. P., Jardel C., Bruckert E., Blondy P., Capeau J., Laville M., Vidal H., Hainque B. (2000): Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J. Clin. Endocrinol. Metab. 85, 3338-3342
4. Bellamy L., Casas J. P., Hingorani A. D., Williams D. (2009): Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373, 1773-1779 http://dx.doi.org/10.1016/S0140-6736(09) 60731-5
5. Bhaumick B., Danilkewich A. D., Bala R. M. (1988): Altered placental insulin and insulin-like growth factor-I receptors in diabetes. Life Sci. 42, 1603-1614 http://dx.doi.org/10.1016/0024-3205(88)90439-0
6. Bouloumie A., Drexler H. C., Lafontan M., Busse R. (1998): Leptin, the product of Ob gene, promotes angiogenesis. Circ. Res. 83, 1059-1066 http://dx.doi.org/10.1161/01.RES.83.10.1059
7. Catalano P. M., Huston L., Amini S. B., Kalhan S. C. (1999): Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am. J. Obstet. Gynecol. 180, 903-916 http://dx.doi.org/10.1016/S0002-9378(99)70662-9
8. Cauzac M., Czuba D., Girard J., Hauguel-de Mouzon S. (2003): Transduction of leptin growth signals in placental cells is independent of JAK-STAT activation. Placenta 24, 378-384 http://dx.doi.org/10.1053/plac.2002.0915
9. Cavaillon J. M. (1995): Les cytokines de l'inflammation: Cytokines et aspects biochimiques de l'inflammation. C. R. Seances Soc. Biol. Fil. 189, 531-544
10. Chaouat G. (1999): Cytokines, équilibre Th1/Th2 et grossesse réussie. Revue française d'allergologie et d'immunologie Clinique 39, 633-642 (in French) http://dx.doi.org/10.1016/S0335-7457(99)80011-2
11. Dandona P., Aljada A., Chaudhuri A., Mohanty P., Garg R. (2005): Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111, 1448-1454 http://dx.doi.org/10.1161/01.CIR.0000158483.13093.9D
12. Enquobahrie D. A., Williams M. A., Qiu C., Meller M., Sorensen T. K. (2009): Global placental gene expression in gestational diabetes mellitus. Am. J. Obstet. Gynecol. 200, 206-213 http://dx.doi.org/10.1016/j.ajog.2008.08.022
13. Esposito K., Pontillo A., Di Palo C., Giugliano G., Masella M., Marfella R., Giugliano D. (2003): Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 289, 1799-1804 http://dx.doi.org/10.1001/jama.289.14.1799
14. Fève B., Bastard J. P., Vidal H. (2006): Les relations entre obésité, inflammation et insulinorésistance : acquisitions récentes. C. R. Biol. 329, 587-597 http://dx.doi.org/10.1016/j.crvi.2006. 03.020
15. Freeman D. J., Norrie J., Caslake M. J., Gaw A., Ford I., Lowe G. D., O'Reilly D. S., Packard C. J., Sattar N. (2002): West of Scotland Coronary Prevention Study: C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51, 1596-1600 http://dx.doi.org/10.2337/diabetes.51.5.1596
16. Galtier F., Raingeard I., Renard E., Boulot P., Bringer J. (2008): Optimizing the outcome of pregnancy in obese women: from pregestational to long-term management. Diabetes Metab. 34, 19-25 http://dx.doi.org/10.1016/j. diabet.2007.12.001
17. Garcia Lloret M. I., Winkler-Lowen B., Guilbert L. J. (2000): Monocytes adhering by LFA-1 to placental syncytiotrophoblasts induce local apoptosis via release of TNF-alpha. A model for hematogenous initiation of placental inflammations. J. Leukoc. Biol. 68, 903-908
18. Grissa O., Yessoufou A., Mrizak I., Hichami A., Amoussou-Guenou D., Grissa A., Djrolo F., Moutairou K., Miled A., Khairi H., Zaouali M., Bougmiza I., Zbidi A., Tabka Z., Khan N. A. (2010): Growth factor concentrations and their placental mRNA expression are modulated in gestational diabetes mellitus: possible interactions with macrosomia. BMC Pregnancy Childbirth 9, 10-17
19. Handwerger S., Freemark M. (2000): The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development. J. Pediatr. Endocrinol. Metab. 13, 343-356 http://dx.doi.org/10.1515/JPEM.2000. 13.4.343
20. Karen M., Yuksel O., Akyürek N., Ofluoǧlu E., Caǧlar K., Sahin T. T., Paşaoǧlu H., Memiş L., Akyürek N., Bostanci H. (2010): Probiotic agent Saccharomyces boulardii reduces the incidence of lung injury in acute necrotizing pancreatitis induced rats. J. Surg. Res. 160, 139-144 http://dx.doi.org/10.1016/j.jss.2009.02.008
21. Khan N. A., Yessoufou A., Kim M., Hichami A. (2006): N-3 fatty acids modulate Th1 and Th2 dichotomy in diabetic pregnancy and macrosomia. J. Autoimmun. 26, 268-277 http://dx.doi.org/10.1016/j.jaut.2006.03.003
22. Kim C., Berger D. K., Chamany S (2007): Recurrence of Gestational Diabetes Mellitus-A Systemic Review. Diabetes care 30, 1314-1319 http://dx.doi.org/10.2337/dc06-2517
23. Kniss D. A., Shubert P. J., Zimmerman P. D., Landon M. B., Gabbe S. G. (1994): Insulinlike growth factors. Their regulation of glucose and amino acid transport in placental trophoblasts isolated from first-trimester chorionic villi. J. Reprod. Med. 39, 249-256
24. Koga K., Mor G. (2010): Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy disorders. Am. J. Reprod. Immunol. 63, 587-600 http://dx.doi.org/10.1111/j.1600-0897.2010.00848.x
25. Krishnaveni G. V., Hill J. C., Veena S. R., Geetha S., Jayakumar M. N., Karat C. L., Fall C. H. (2007): Gestational diabetes and the incidence of diabetes in the 5 years following the index pregnancy in South Indian women. Diabetes Res. Clin. Pract. 78, 398-404 http://dx.doi.org/10.1016/j.diabres.2007. 06.002
26. Lappas M., Yee K., Permezel M., Rice G. E. (2005): Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellituscomplicated pregnancies. J. Endocrinol. 186, 457-465 http://dx.doi.org/10.1677/joe.1.06227
27. Lee H., Jang H. C., Park H. K., Metzger B. E., Cho N. H. (2008): Prevalence of type 2 diabetes among women with a previous history of gestational diabetes mellitus. Diabetes Res. Clin. Pract. 81, 124-129 http://dx.doi.org/10. 1016/j.diabres.2008.02.017
28. Lepercq J., Catalano P., Hauguel De Mouzon S. (2007): Leptine et grossesse : dogmes, questions et perspectives. Gynecol. Obstet. Fertil. 35, 89-95 http://dx.doi.org/10.1016/j.gyobfe.2006.12.015
29. Lepercq J., Cauzac M., Lahlou N., Timsit J., Girard J., Auwerx J., Hauguel De Mouzon S. (1998): Overexpression of placental leptin in diabetic pregnancies: a critical role for insulin. Diabetes 47, 847-850 http://dx.doi.org/10.2337/diabetes.47.5.847
30. Li L., Kang J., Lei W. (2010): Role of Toll-like receptor 4 in inflammation- induced preterm delivery. Mol. Hum. Reprod. 16, 267-272 http://dx.doi.org/10.1093/molehr/gap106
31. Lin Y., Xie M., Chen Y., Di J., Zeng Y. (2006): Preterm delivery induced by LPS in syngeneically impregnated BALB/c and NOD/SCID mice. J. Reprod. Immunol. 71, 87-101 http://dx.doi.org/10.1016/j.jri.2006.01.005
32. Loffreda S., Yang S. Q., Lin H. Z., Karp C. L., Brengman D. J., Wang A. S., Klein G. B., Bulkley C., Bao P. W., Noble M. D., Lane M. L., Diehl A. M. (1998): Leptin regulates proinflammatory immune responses. FASEB J. 12, 57-65
33. McCracken S. A., Hadfield K., Rahimi Z., Gallery E. D., Morris J. M. (2007): NF-kappaB-regulated suppression of T-bet in T cells represses Th1 immune responses in pregnancy. Eur. J. Immunol. 37, 1386-1396 http://dx.doi.org/10. 1002/eji.200636322
34. Meller M., Qiu C., Vadachkoria S., Abetew D. F., Luthy D. A., Williams M. A. (2006): Changes in placental adipocytokine gene expression associated with gestational diabetes mellitus. Physiol. Res. 55, 501-512
35. Ozuguz U., Isik S., Berker D., Arduc A., Tutuncu Y., Akbaba G., Gokay F., Guler S. (2011): Gestational diabetes and subclinical inflammation: Evaluation of first year postpartum outcomes. Diabetes Res. Clin. Pract. 94, 426-433 http://dx.doi.org/10.1016/j.diabres.2011.08.024
36. Pittas A. G., Joseph N. A., Greenberg A. S. (2004): Adipocytokines and insulin resistance. J. Clin. Endocrinol. Metab. 89, 447-452 http://dx.doi.org/ 10.1210/jc.2003-031005
37. Radaelli T., Varastehpour A., Catalano P., Hauguel-de Mouzon S. (2003): Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes 52, 2951-2958 http://dx.doi.org/10.2337/diabetes.52.12.2951
38. Ranheim T., Haugen F., Staff A. C., Braekke K., Harsem N. K., Drevon C. A. (2004): Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta Obstet. Gynecol. Scand. 83, 341-347 http://dx.doi.org/10. 1080/j.0001-6349.2004.00413.x
39. Reece E. A., Leguizamón G., Wiznitzer A. (2009): Gestational diabetes: the need for a common ground. Lancet 373, 1789-1797 http://dx.doi.org/10.1016/S0140-6736(09)60515-8
40. Richardson A. C., Carpenter M. W. (2007): Inflammatory mediators in gestational diabetes mellitus. Obstet. Gynecol. Clin. North. Am. 34, 213-224 http://dx.doi.org/10.1016/j.ogc.2007.04.001
41. Sedlik C. (1996): Les sous-populations de lymphocytes Thl et Th2 : caractérisation, rô1e physiologique et régulation. Bull. Inst. Pasteur 94, 173-200 (in French) http://dx.doi.org/10.1016/S0020-2452(97) 86016-2
42. Torloni M. R., Betrán A. P., Horta B. L., Nakamura M. U., Atallah A. N., Moron A. F., Valente O. (2009): Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes. Rev. 10, 194-203 http://dx.doi.org/10.1111/j.1467-789X.2008.00541.x
43. Tsigos C., Papanicolaou D. A., Kyrou I., Defensor R., Mitsiadis C. S., Chrousos G. P. (1997): Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J. Clin. Endocrinol. Metab. 82, 4167-4170 http://dx.doi.org/10.1210/jcem.82.12.4422
44. Uzelac P. S., Li X., Lin J., Neese L. D., Lin L., Nakajima S. T., Bohler H., Lei Z. (2010): Dysregulation of leptin and testosterone production and their receptor expression in the human placenta with gestational diabetes mellitus. Placenta 31, 581-588 http://dx.doi.org/10.1016/j.placenta.2010.04.002
45. Viardot A., Grey S. T., Mackay F., Chisholm D. (2007): Potential anti-inflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype. Endocrinology 148, 346-353 http://dx.doi.org/10.1210/en.2006-0686
46. Wroblewska-Seniuk K., Wender-Ozegowska E., Szczapa J. (2009): Long-term effects of diabetes during pregnancy on the offspring. J. Pediatr. Diabetes 10, 432-440 http://dx.doi.org/10.1111/j.1399-5448.2009.00507.x
47. Yamagishi S. I., Edelstein D., Du X. L., KanedaY., Guzman M., Brownlee M. (2001): Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J. Biol. Chem. 276, 25096-25100 http://dx.doi.org/10.1074/jbc.M007383200
48. Yogev Y., Catalano P. M. (2009): Pregnancy and obesity. Obstet. Gynecol. Clin. North. Am. 36, 285-300 http://dx.doi.org/10.1016/j.ogc.2009.03.003